About 108 results

ALLMedicine™ Substance Use Center - Guidelines

Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences

Major neurocognitive changes occur during adolescence, making this phase one of the most critical developmental periods of life. Furthermore, this phase in life is also the time in which youth substance use begins. Several studies have demonstrated the differential associations of alcohol and cannabis use concerning the neurocognitive functioning of both males and females. Past and contemporary...

Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders

Bipolar disorder (BD) frequently co-occurs with substance use disorders (SUDs), and both are associated with cognitive impairment. This study compares cognition between individuals with BD with and without current alcohol use disorder (AUD), cocaine use disorder (CUD), or both, as these disorders may be linked with additive cognitive impairment.

Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic
JAMA Psychiatry; Holland KM, .

Feb 2nd, 2021 - Importance The coronavirus disease 2019 (COVID-19) pandemic, associated mitigation measures, and social and economic impacts may affect mental health, suicidal behavior, substance use, and violence.

Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Sharon Schutte-Rodin

Oct 14th, 2008 - Insomnia symptoms occur in approximately 33% to 50% of the adult population, insomnia symptoms with distress or impairment (general insomnia disorder) in 10% to 15%. Consistent risk factors for insomnia include increasing age, female sex, comorbid (medical, psychiatric, sleep, and substance use) disorders, shift work, and possibly unemployment and lower socio-economic status.

Defining and Implementing a Public Health Response to Drug Use and Misuse
American Public Health Association

Nov 4th, 2013 - Drug use and misuse continue to create public health challenges in the United States, leading to overdose deaths, HIV and hepatitis C infections, and other chronic health conditions. Public health approaches offer effective, evidence-based responses, but some of the most effective interventions are not currently allowed in the United States owing to outdated drug laws, attitudes, and stigma.

Joint Public Correctional Policy Statement on the Treatment of Opioid Use Disorders for Just...
American Society of Addiction Medicine (ASAM)

May 11th, 2018 - The American Correctional Association (ACA) supports the use of evidence-based practices for the treatment of opioid use disorders. ACA and the American Society of Addiction Medicine (ASAM) have developed recommendations specific to the needs of correctional policy makers and healthcare professionals.

Measures to Counteract Prescription Drug Diversion, Misuse and Addiction: ASAM Guideline
American Society of Addiction Medicine

Jan 24th, 2012 - The diversion of prescription drugs from the person to whom they were originally prescribed, and the non-medical, sometimes lethal use of these drugs, are components of our nation's overall drug problem, and they are of special concern to physicians. The last two decades have seen dramatic increases in the use of and addiction to potentially addictive pharmaceuticals.

Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College o...
Chou R, Cruciani RA et. al.

Mar 31st, 2014 - The American Pain Society (APS) and the College on Problems of Drug Dependence (CPDD), in collaboration with the Heart Rhythm Society (HRS), commissioned an interdisciplinary panel to develop a clinical practice guide- line on safer prescribing of methadone for treatment of opioid addiction and chronic pain. As part of the guideline development process, APS commissioned a systematic re- view on.

mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Special...

Jan 11th, 2016 - Mental, neurological and substance use (MNS) disorders are highly prevalent, accounting for a substantial burden of disease and disability globally. In order to bridge the gap between available resources and the significant need for services, the World Health Organization launched the Mental Health Gap Action Programme (mhGAP).

Position Statement 11: In Support of Recovery-Based Systems Transformation
National Mental Health America

Sep 11th, 2015 - MHA believes mental health and substance abuse systems transformation will occur only when all stakeholders view recovery as the primary goal, defined broadly as a journey of healing and transformation enabling a person with a mental health or substance use condition to live a meaningful life in a community of his or her choice while striving to achieve his or her full potential.

Hepatitis C Infection: ASAM Guideline
American Society of Addiction Medicine

Apr 4th, 2017 - HCV is primarily transmitted through percutaneous exposure to contaminated blood. Since 1992, the US blood supply has been screened for Hepatitis C, making the risk of transfusion-transmitted HCV extremely rare.

Inclusion of Addiction Specialist Physicians in Managed Behavioral Health Care Organization ...
American Society of Addiction Medicine

Jul 24th, 2018 - Patients presenting with substance-related and addictive disorders often face barriers to obtaining successful treatment due to the stigma associated with the disease, insufficient access to high quality care including skilled clinicians, and gaps in the continuum of treatment available to treat their disorders. Patients who do avail themselves of treatment often access these services through m.

Position Statement 12: Evidence-Based Healthcare
National Mental Health America

Mar 4th, 2016 - Mental Health America (MHA) is dedicated to accelerating the application of scientific and practical knowledge to help in the recovery of people with mental health and substance use conditions. This focus on evidence-based healthcare spans the development, exposition, evaluation, replication, translation, dissemination and implementation of knowledge about mental health and substance use disord.

Position Statement 16: Addressing the Health- Related Social Needs of People with Mental Hea...
National Mental Health America

Sep 8th, 2017 - Mental Health America (MHA) calls for dedication of significant state and federal resources to reduce the alarmingly high rates of overall health problems (morbidity) and premature death (mortality) among people with serious mental illnesses, – which must include an array of strategies for addressing health-related social needs. With the addition of effective surveillance and treatment services.

Position Statement 17: Promotion of Mental Wellness
National Mental Health America

Dec 4th, 2015 - The very significant body of evidence that has been developed about prevention of mental and substance use conditions and promotion of mental health should encourage policy makers to invest in proven prevention and wellness interventions. Well-studied prevention and mental health promotion interventions can improve overall functioning as well as decrease the rates at which individuals develop.

Prescription Drug Monitoring Programs (PDMPs)
American Society of Addiction Medicine (ASAM)

Apr 10th, 2018 - Prescription Drug Monitoring Programs (PDMPs) are statewide electronic databases that collect designated data from pharmacies and medical offices that dispense controlled substances in the state. PDMPs are maintained at the state level and housed in various statewide regulatory, administrative, or law enforcement agencies.

Pharmacological Treatment of Patients with Alcohol Use Disorder
Victor I. Reus

Dec 31st, 2017 - The goal of this guideline is to improve the quality of care and treatment outcomes for patients with alcohol use disorder (AUD), as defined by DSM-5 (American Psychiatric Association 2013). The guideline focuses specifically on evidence-based pharmacological treatments for AUD but also includes statements related to assessment and treatment planning that are an integral part of using pharmacot.

Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on...
American Society of Addiction Medicine

Jan 17th, 2017 - The American Society of Addiction Medicine (ASAM) is deeply committed to the health and well-being of mothers and children. This includes advocating for prevention and treatment of substance-related harm throughout a woman's reproductive years, with a particular focus on addiction and substance use during and following pregnancy.